Connect with Us! Facebook Twitter Social Media
Coalitions

2017-02-14 Coalitions Bi-Monthly Webinars
Topic: CDC-USBC Bi-monthly Coalitions Webinars
Owner: USBC Coalitions Staff
Date: 2017-02-14
Subtopic: 062

Landscape of Donor Milk in the United States

Presented by:
Pauline Sakomoto, Executive Director, Mothers' Milk Bank
Past-President, Human Milk Banking Association of North America 

The Surgeon Generals Call to Action, Action 12, related to donor milk states, Identify and address obstacles to greater availability of safe banked donor milk for fragile infants. Evidence supports the critical role of donated human milk in assisting infants with special needs, such as infants in newborn intensive care units who are unable to receive their own mothers’ milk, to achieve the best possible health outcome. This session will provide a brief history of the emergence of human milk banks, members of the Human Milk Banking Association of North America (HMBANA), and talk about challenges to reducing the barriers to greater availability of banked human milk within the context of breastfeeding inequities, disparities in birth outcomes and the state of motherhood in the United States. In December 2016, the American Academy of Pediatrics presented a Position paper on Donor Human Milk for the High Risk Infant: Preparation, Safety, and Usage Options in the United States.  There has been a growing recognition of the effectiveness and safety of donor human milk in the neonatal care setting and increasing interest of donor milk use in the newborn nurseries.  This presentation will speak about the emerging landscape of milk collection and distribution from various entities and how to address the Surgeon General’s Call to Action and the AAP Policy for greater availability of safe banked donor milk for fragile infants. This session will address:

  • What is the barrier to equitable distribution of human milk?
  • How do we address the various access methods to milk for families?
  • Who are the players in the conversation of distribution?
  • Why is it a public health imperative that needs to be addressed globally?

Download File View File   2017-02-14-Webinar-Slides.pdf